These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 15592503

  • 1. In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy.
    Xi S, Gooding WE, Grandis JR.
    Oncogene; 2005 Feb 03; 24(6):970-9. PubMed ID: 15592503
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
    Zhang X, Zhang J, Wang L, Wei H, Tian Z.
    BMC Cancer; 2007 Aug 04; 7():149. PubMed ID: 17683579
    [Abstract] [Full Text] [Related]

  • 3. Epidermal growth factor receptor--mediated stat3 signaling blocks apoptosis in head and neck cancer.
    Rubin Grandis J, Zeng Q, Drenning SD.
    Laryngoscope; 2000 May 04; 110(5 Pt 1):868-74. PubMed ID: 10807365
    [Abstract] [Full Text] [Related]

  • 4. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L, Zhang L, Hu J, Li F, Shao Y, Zhao D, Kalvakolanu DV, Kopecko DJ, Zhao X, Xu DQ.
    Clin Cancer Res; 2005 Sep 01; 11(17):6333-41. PubMed ID: 16144938
    [Abstract] [Full Text] [Related]

  • 5. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
    Masuda M, Suzui M, Yasumatu R, Nakashima T, Kuratomi Y, Azuma K, Tomita K, Komiyama S, Weinstein IB.
    Cancer Res; 2002 Jun 15; 62(12):3351-5. PubMed ID: 12067972
    [Abstract] [Full Text] [Related]

  • 6. STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo.
    Kijima T, Niwa H, Steinman RA, Drenning SD, Gooding WE, Wentzel AL, Xi S, Grandis JR.
    Cell Growth Differ; 2002 Aug 15; 13(8):355-62. PubMed ID: 12193474
    [Abstract] [Full Text] [Related]

  • 7. Antiproliferative mechanisms of a transcription factor decoy targeting signal transducer and activator of transcription (STAT) 3: the role of STAT1.
    Lui VW, Boehm AL, Koppikar P, Leeman RJ, Johnson D, Ogagan M, Childs E, Freilino M, Grandis JR.
    Mol Pharmacol; 2007 May 15; 71(5):1435-43. PubMed ID: 17325127
    [Abstract] [Full Text] [Related]

  • 8. Constitutive activation of Stat5b contributes to carcinogenesis in vivo.
    Xi S, Zhang Q, Gooding WE, Smithgall TE, Grandis JR.
    Cancer Res; 2003 Oct 15; 63(20):6763-71. PubMed ID: 14583472
    [Abstract] [Full Text] [Related]

  • 9. The nonsteroidal anti-inflammatory drug sulindac causes down-regulation of signal transducer and activator of transcription 3 in human oral squamous cell carcinoma cells.
    Nikitakis NG, Hamburger AW, Sauk JJ.
    Cancer Res; 2002 Feb 15; 62(4):1004-7. PubMed ID: 11861373
    [Abstract] [Full Text] [Related]

  • 10. Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines.
    Sumita N, Bito T, Nakajima K, Nishigori C.
    Exp Dermatol; 2006 Apr 15; 15(4):291-9. PubMed ID: 16512876
    [Abstract] [Full Text] [Related]

  • 11. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA, Xi S, Pomerantz RG, Lin CJ, Gooding WE, Wentzel AL, Wu L, Sidransky D, Grandis JR.
    Head Neck; 2004 Oct 15; 26(10):870-7. PubMed ID: 15390206
    [Abstract] [Full Text] [Related]

  • 12. Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.
    Song JI, Lango MN, Hwang JD, Drenning SD, Zeng Q, Lamph WW, Grandis JR.
    Cancer Res; 2001 Aug 01; 61(15):5919-25. PubMed ID: 11479234
    [Abstract] [Full Text] [Related]

  • 13. STAT3-decoy oligodeoxynucleotide inhibits the growth of human lung cancer via down-regulating its target genes.
    Zhang X, Zhang J, Wei H, Tian Z.
    Oncol Rep; 2007 Jun 01; 17(6):1377-82. PubMed ID: 17487394
    [Abstract] [Full Text] [Related]

  • 14. STAT proteins: novel molecular targets for cancer drug discovery.
    Turkson J, Jove R.
    Oncogene; 2000 Dec 27; 19(56):6613-26. PubMed ID: 11426647
    [Abstract] [Full Text] [Related]

  • 15. [Relationship of Stat3 and its target gene products with malignancy in human colorectal carcinoma].
    Ma XT, Wang S, Ye YJ, Du RY, Cui ZR.
    Ai Zheng; 2003 Nov 27; 22(11):1135-9. PubMed ID: 14613639
    [Abstract] [Full Text] [Related]

  • 16. Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis.
    Xi S, Dyer KF, Kimak M, Zhang Q, Gooding WE, Chaillet JR, Chai RL, Ferrell RE, Zamboni B, Hunt J, Grandis JR.
    J Natl Cancer Inst; 2006 Feb 01; 98(3):181-9. PubMed ID: 16449678
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.
    Weerasinghe P, Garcia GE, Zhu Q, Yuan P, Feng L, Mao L, Jing N.
    Int J Oncol; 2007 Jul 01; 31(1):129-36. PubMed ID: 17549413
    [Abstract] [Full Text] [Related]

  • 18. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
    Hellsten R, Johansson M, Dahlman A, Dizeyi N, Sterner O, Bjartell A.
    Prostate; 2008 Feb 15; 68(3):269-80. PubMed ID: 18163422
    [Abstract] [Full Text] [Related]

  • 19. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids.
    Selvendiran K, Koga H, Ueno T, Yoshida T, Maeyama M, Torimura T, Yano H, Kojiro M, Sata M.
    Cancer Res; 2006 May 01; 66(9):4826-34. PubMed ID: 16651438
    [Abstract] [Full Text] [Related]

  • 20. G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis.
    Jing N, Li Y, Xiong W, Sha W, Jing L, Tweardy DJ.
    Cancer Res; 2004 Sep 15; 64(18):6603-9. PubMed ID: 15374974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.